The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients - Related Studies

The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients

This study has been completed.

Study NCT00002431. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Candidiasis, Oral
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Candidiasis
		Communicable Diseases
		Infection

3	More general conditions related to this trial
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Mouth Diseases
		Mycoses
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Stomatognathic Diseases
		Virus Diseases

4	Interventions listed in this trial
		Chlorhexidine gluconate

5	Additional drug interventions recognized in this trial
		Chlorhexidine

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Anti-Infective Agents, Local
		Dermatologic Agents
		Disinfectants
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Procter and Gamble